| (₹ crores) | Q2FY26 | Q1FY26 | Q2FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 823.90 | 782.90 | 708.20 | 5.2% | 16.3% |
Total Expenses | 690.80 | 630.80 | 584.10 | 9.5% | 18.3% |
Profit Before Tax | 133.10 | 152.10 | 124.10 | -12.5% | 7.3% |
Tax | 31.00 | 35.70 | 32.40 | -13.2% | -4.3% |
Profit After Tax | 102.10 | 116.40 | 91.70 | -12.3% | 11.3% |
Earnings Per Share | 4.23 | 4.82 | 3.80 | -12.2% | 11.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Indegene Ltd is a company operating within the healthcare and life sciences industry. It primarily focuses on providing healthcare solutions that integrate technology, medical expertise, and analytics to enhance healthcare delivery and patient outcomes. The company offers products and services such as medical communications, commercial operations management, and digital transformation services tailored for pharmaceutical and biotechnology companies. As of the last available data, there have been no specific major developments publicly disclosed for Indegene Ltd. Further information on strategic initiatives or recent changes in the company's operations is currently not available.
For the second quarter of fiscal year 2026 (Q2FY26), Indegene Ltd reported a total income of ₹823.90 crores, marking a quarter-over-quarter (QoQ) growth of 5.2% compared to ₹782.90 crores in the first quarter of fiscal year 2026 (Q1FY26). Year-over-year (YoY), this represents a 16.3% increase from ₹708.20 crores in the second quarter of fiscal year 2025 (Q2FY25). This growth trajectory in revenue reflects the company's capability to enhance its income streams over the comparable periods, suggesting robust operational performance in generating revenue.
Indegene Ltd's profitability for Q2FY26 indicates a profit before tax of ₹133.10 crores, which is a decrease of 12.5% from the ₹152.10 crores reported in Q1FY26. Compared to Q2FY25, this represents a 7.3% increase from ₹124.10 crores. The tax expenses for Q2FY26 were ₹31.00 crores, down by 13.2% QoQ and by 4.3% YoY. Consequently, the profit after tax for Q2FY26 was ₹102.10 crores, reflecting a 12.3% decrease from the previous quarter's ₹116.40 crores but an 11.3% increase from the ₹91.70 crores in Q2FY25. The earnings per share (EPS) for Q2FY26 were ₹4.23, compared to ₹4.82 in Q1FY26 and ₹3.80 in Q2FY25.
In terms of operating metrics, Indegene Ltd's total expenses increased by 9.5% QoQ from ₹630.80 crores in Q1FY26 to ₹690.80 crores in Q2FY26. Year-over-year, this represents an 18.3% rise from ₹584.10 crores in Q2FY25. The increase in expenses may reflect operational adjustments or expansions to support its revenue growth. The company's ability to manage its expenses while still achieving YoY growth in profit after tax indicates operational efficiency in its financial management.
Indegene Ltd announced its Q2 FY 2025-26 results on 1 November, 2025.
Indegene Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Indegene Ltd Q2 FY 2025-26 results include:
Indegene Ltd reported a net loss of ₹102.10 crore in Q2 FY 2025-26, reflecting a 11.3% year-over-year growth.
Indegene Ltd posted a revenue of ₹823.90 crore in Q2 FY 2025-26.